BACKGROUND
- This protocol acknowledges that it is in the interest of the NIH and ROB, as well as
our participants, to continue to follow those who have been treated with
radiotherapy at ROB and are not otherwise eligible for current active research
protocols.
- It also provides a mechanism for the correlation and interpretation of disparate
data for research into the long term side effects and outcomes for a variety of
disease entities and treatments, such as combined modality treatment, MoAb, PDT,
radiation modifiers,
intraoperative radiotherapy, etc.
OBJECTIVE
-The primary objective of this protocol is to assess the late effects of treatment and
the natural history of disease through collection of data from any standard procedures
performed as part of follow up care on participants previously treated with radiotherapy.
ELIGIBILITY
-Participants who received radiation therapy.
DESIGN
- This is a natural history protocol in which long-term follow up data will be
collected from participants who received radiation therapy.
- It will be made clear to participants in the consent form, that data collected
during their follow-up may be used anonymously for publications concerning the
natural history of disease processes and long-term effects of treatment.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT00026650.
Locations matching your search criteria
United States
Maryland
Bethesda
National Institutes of Health Clinical CenterStatus: Active
Contact: National Cancer Institute Referral Office
Phone: 888-624-1937
BACKGROUND
- This protocol acknowledges that it is in the interest of the NIH and ROB, as well as
our participants, to continue to follow those who have been treated with
radiotherapy at ROB and are not otherwise eligible for current active research
protocols.
- It also provides a mechanism for the correlation and interpretation of disparate
data for research into the long term side effects and outcomes for a variety of
disease entities and treatments, such as combined modality treatment, MoAb, PDT,
radiation modifiers,
intraoperative radiotherapy, etc.
OBJECTIVE
-The primary objective of this protocol is to assess the late effects of treatment and
the natural history of disease through collection of data from any standard procedures
performed as part of follow up care on participants previously treated with radiotherapy.
ELIGIBILITY
-Participants who received radiation therapy.
DESIGN
- This is a natural history protocol in which long-term follow up data will be
collected from participants who received radiation therapy.
- It will be made clear to participants in the consent form, that data collected
during their follow-up may be used anonymously for publications concerning the
natural history of disease processes and long-term effects of treatment.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationNational Cancer Institute
Principal InvestigatorKevin Camphausen
